Early-onset herpes simplex encephalitis type 1 triggered by COVID-19 disease: A case report.

Acyclovir COVID-19 HSV-1 encephalitis Reactivation Vidarabine

Journal

Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 22 08 2023
revised: 14 11 2023
accepted: 17 11 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) causes a systemic inflammatory response and a temporary immunosuppression of hosts. Several reports have showed that reactivation of herpes simplex virus type 1 (HSV-1) is strongly associated with COVID-19. We present a case of a 66-year-old female, who developed HSV-1 encephalitis, showing impaired consciousness and typical MRI findings such as hyperintense lesions in the temporal lobe, insular cortices, bilateral medial frontal lobe on diffusion-weighted imaging, 7 days after the onset of COVID-19 symptoms. The number of cases of encephalitis in patients with COVID-19 is increasing. However, there has been limited reports of HSV-1 encephalitis following COVID-19, especially for cases with an interval of 7 days or less from the onset of COVID-19 symptoms to the onset of HSV-1 encephalitis. Our case highlights the importance of considering HSV-1 encephalitis in the differential when managing a patient with COVID-19-associated neurologic complications, even if it is in the early stages of COVID-19.

Identifiants

pubmed: 38188949
doi: 10.1016/j.radcr.2023.11.044
pii: S1930-0433(23)00868-3
pmc: PMC10770472
doi:

Types de publication

Case Reports

Langues

eng

Pagination

855-858

Informations de copyright

© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Auteurs

Kai Inoue (K)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Hanako Aoki (H)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Shuta Toru (S)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Yu Hatano (Y)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Reina Imase (R)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Hiroshi Takasaki (H)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Michiko Tanaka (M)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Saori Adachi (S)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Hiroaki Yokote (H)

Department of Neurology, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Hideki Akiyama (H)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Michio Yamane (M)

Department of Internal Medicine, Nitobe Memorial Nakano General Hospital, Nakano-ku, Tokyo, Japan.

Classifications MeSH